• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA approves Medtronic’s Pipeline Flex aneurysm device

FDA approves Medtronic’s Pipeline Flex aneurysm device

February 5, 2015 By Brad Perriello

FDA approves Medtronic's Pipeline Flex aneurysm device

Medtronic (NYSE:MDT) said today that the FDA approved the Pipeline Flex embolization device it acquired along with Covidien last month, revealing plans for a limited U.S. release of the brain aneurysm treatment.

The latest iteration of the Pipeline device is designed to treat large and giant aneurysms by preventing blood from flowing into them, according to a press release.

Pipeline Flex, which Covidien itself bought along with ev3 for $2.3 billion in 2010, is indicated for complex intracranial aneurysms that can’t be clipped and are attached to parent vessels measuring between 2.5mm and 5.0mm in diameter, according to the release. The device won CE Mark approval in the European Union last June.

"Flow diversion has been a major breakthrough therapy for large or giant wide-necked brain aneurysms that are complex and have considerably higher risk of rupture and higher rates of complication with conventional treatment," Dr. Ricardo Hanel of Florida’s Baptist Health said in prepared remarks. "With thousands of patients successfully treated with Pipeline embolization device, the Pipeline Flex’s innovative delivery system will result in further advancing endovascular treatment and care."

"The Pipeline Flex embolization device is the next advancement in flow diversion, combining our clinically-proven braid design with a new delivery system designed to offer improved accuracy and control when performing these advanced procedures inside the brain," Medtronic’s neurovascular president Brett Wall said in prepared remarks. "We are excited to bring new value to our medical community and patients."

The original Pipeline device, which 1st won a PMA nod from the FDA in April 2011, ran into trouble last year when Covidien issued an April recall for it and its Alligator retrieval device. Five months later Covidien had fixed the potentially lethal problem affecting the coating on the devices’ guidewires, winning FDA clearance in August 2014 to get them back on the U.S. market.

Medtronic paid $50 billion for Covidien last month in the largest medical device merger ever.

Filed Under: Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Covidien, Neurovascular repair

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy